Clinical Trial

Impact of Capillaroscopy in the Investigation of Diffuse Interstitial Pneumonias

Study acronym: CAPID
Recruiting
View on ClinicalTrials.gov →
Summary
The investigators hypothesize that in patients with a new diagnosis of Pulmonary Interstitial Disease (PID), adding capillaroscopy to standard care increases the proportion of patients receiving a diagnosis of PID-Connective Tissue Disease (PID-CTD) within the first three months of follow-up, thereby reducing the time to diagnosis and facilitating the implementation of appropriate treatment as quickly as possible. Therefore, To confirm this hypothesis, it is necessary to know the characteristics of capillaroscopy in patients with a new diagnosis of PID.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-12-02.
Status change: Not Yet Recruiting → Recruiting 2026-03-17
Trial Details
NCT Number NCT07283081
Lead Sponsor University Hospital, Bordeaux
Conditions Interstitial Lung Disease, Connective Tissue Diseases
Enrollment 48 participants
Start Date 2026-03-16
Primary Completion 2027-03 (estimated)
Study Completion 2027-03 (estimated)
Updated on ClinicalTrials.gov 2026-03-20